Organizations strategically deploy their forces; structural opportunities have become a consensus in the market.

Recently, several A-share listed companies such as Shijia Guangzi, Dongfang Biotech, and Meiwei Biotech disclosed the latest top ten shareholders due to repurchase and other matters. The portfolio adjustments of many well-known fund managers such as Jin Zicai, Wan Minyuan, Jin Xiaofei, and Lu Bin have emerged. In addition, many well-known foreign institutions such as Barclays Bank, UBS, and J.P. Morgan Securities have been increasing their holdings in A-share listed companies. As 2025 approaches the halfway mark, the market is entering a critical period. Some industry insiders predict that on one hand, the decision-makers are expected to further strengthen the strategic orientation of self-reliance in technology and consumption boost, while financial and monetary policies will remain loose; on the other hand, industries with significantly improved half-year performance expectations deserve special attention.